Loading
A phase 2 trial in colorectal cancer, run by Pusan National University Yangsan Hospital, now recruiting.
Fluorescence Lymph Node Mapping for Colon Cancer Surgery is a phase 2, randomised interventional study registered as NCT07060443 by Pusan National University Yangsan Hospital, with a registry enrolment figure of 186 participants, started 2025-07-23 and due to reach its primary completion in 2028-12-31. Interventions recorded: Indocyanine green (ICG) injection for intraoperative lymph node imaging; Standard Right Hemicolectomy (Non-ICG). Conditions listed: Right Hemicolectomy. Primary outcome: Pathological D3 lymph node metastasis detection rate. Colorectal eligibility wording from the registry: "Patient with locally advanced right colon cancer requiring D3 lymphadenectomy". Sites: South Korea. No results are recorded here; the registry entry is the source.
Shares Robotic & minimally invasive surgery, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.